The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollment

Posted by author-avatar

Publication date: Available online 11 March 2026

Source: Urology

Author(s): Paz Lotan, Andrew L. Wentland, Daniel D. Shapiro, Matthew R. Smith, Daniel F. Roadman, Glenn O. Allen, David F. Jarrard, Kye Nichols, Michael C. Risk, Kyle A. Richards, Elizabeth L. Koehne, E. Jason Abel

Read More

Newer
Reply to Editorial Comment on “Longitudinal Trends in Urology In-Service Examination Performance: 2016 – 2023”
Older Understanding patient and surgeon priorities in prostate enucleation surgery: Insights from the ENUC-TR multicenter cross-sectional study